| C | Comparator |
| CI | Confidence interval |
| CKAP2L | Cytoskeleton-associated protein 2-like |
| COX-2 | Cyclooxygenase 2 |
| GWAS | Genome-wide association studies |
| I | Intervention |
| IL | Interleukin |
| JAK | Janus activated kinase |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| MAPK | mitogen activated protein kinase |
| MMPs | Matrix metalloproteinases |
| NF-κB | Nuclear factor kappa B cell |
| NRS | Numerical rating scale |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| O | Outcome |
| OCPs | Oral contraceptive pills |
| P | Population |
| PCOS | Polycystic ovary syndrome |
| PGs | Prostaglandins |
| RCTs | Randomized clinical trials |
| ROB | Risk-of-bias |
| RoB 2 | Cochrane risk of bias |
| SMD | Standardized mean difference |
| SRMA | Systemic review meta-analysis |
| STAT3 | Signal transducer and activator of transcription 3 |
| TNF-α | Tumor necrosis factor-alpha |
| V.C | Vasoconstriction |
| VAS | Visual analogue scale |
| VDR | Vitamin D receptor |
| VEGF | Vascular endothelial growth factor |
| Vit. D2 | Ergocalciferol |
| Vit. D3 | Cholecalciferol |
| Vit.D | Vitamin D |